Orgenesis Inc. | Ownership
Companies that own Orgenesis Inc.
The Vanguard Group, Inc.
143,392
0.96%
143,392
0%
06/30/2018
BlackRock Fund Advisors
17,876
0.12%
17,876
0%
06/30/2018
PanAgora Asset Management, Inc.
10,694
0.07%
6,068
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
10,125
0.07%
0
0%
06/30/2018
Alumot Sprint Mutual Funds Management Ltd.
3,615
0.02%
0
0.04%
05/31/2018
Vanguard Fiduciary Trust Co.
1,425
0.01%
1,425
0%
06/30/2018
Citigroup Global Markets, Inc. (Investment Management)
1,303
0.01%
0
0%
06/30/2018
BlackRock Investment Management LLC
1,291
0.01%
1,291
0%
06/30/2018
Winslow, Evans & Crocker, Inc. (Investment Management)
1,000
0.01%
0
0%
06/30/2018
SevenBridge Financial Group LLC
250
0%
0
0%
06/30/2018
| Address |
20271 Goldenrod Lane
Germantown Maryland 20876
United States
|
|
Employees
|
- |
| Website |
http://www.orgenesis.com |
| Updated |
07/08/2019 |
| Orgenesis, Inc. engages in the cell therapy development and manufacturing for advanced medicinal products. It focuses on developing novel and proprietary cell therapy trans-differentiation technologies for the treatment of diabetes. It operates through the Contract Development and Manufacturing Organization (CDMO), and Cellular Therapy Business (CT) segments. |
